ArticleAmerican journal of clinical dermatology2026
48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients.
Teppei Hagino et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it